| 序号 |
标题 |
次数 |
作者 |
发布时间 |
| 74881 |
RGD修饰的共载姜黄素和阿霉素脂质体,cRGD-(C+D/LP)，提供荧光脂质体定制服务 |
91 |
axc |
2024-12-18 |
| 74882 |
螯合剂DOTA-NHS |
88 |
h |
2024-12-18 |
| 74883 |
Mal-PEG2-Val-Ala-PAB-PNP，马来酰亚胺-二聚乙二醇-VAL-ALA-PAB-PNP 酯 |
105 |
kx |
2024-12-18 |
| 74884 |
1,4,7,10-四氮杂环十二烷-N,N,N,N-四乙酸(DOTA)螯合物偶联配体[SHALs]) |
86 |
h |
2024-12-18 |
| 74885 |
DOTA(Gd))-b-PCL DOTA(Gd)螯合物修饰聚己内酯聚合物胶束 |
83 |
h |
2024-12-18 |
| 74886 |
土贝母苷甲脂质体，Tub,I-LPs，载药脂质体定制服务 |
79 |
axc |
2024-12-18 |
| 74887 |
半乳糖-RGD2 Galacto-RGD2 |
103 |
h |
2024-12-18 |
| 74888 |
DOTA-dPEG2-R954 DOTA偶联B1R拮抗剂R954 |
80 |
h |
2024-12-18 |
| 74889 |
竹节参皂苷Ⅳa脑靶向脂质体，脂质体纳米载体定制服务 |
120 |
axc |
2024-12-18 |
| 74890 |
cas:253863-34-2，Aloc-D-Ala-Phe-Lys(Aloc)-PAB-PNP，ADC定制 |
82 |
wyh |
2024-12-18 |
| 74891 |
CAS: 1343407-91-9 Alloc-Val-Ala-PAB（或Val-Ala-PAB-OH） |
87 |
WYQ |
2024-12-18 |
| 74892 |
DOTA-PEG-NH2 DOTA-聚乙二醇-氨基 |
94 |
h |
2024-12-18 |
| 74893 |
R-8PEG-4PCL的介绍 |
81 |
zyl |
2024-12-18 |
| 74894 |
N3-tri-EG-OPFP，ADC定制 |
73 |
wyh |
2024-12-18 |
| 74895 |
cas:1949793-41-2， Mal-amido-PEG4-Val-Cit-PAB-OH，马来酰亚胺-四聚乙二醇-VAL-CIT-PAB |
76 |
kx |
2024-12-18 |
| 74896 |
甘露糖修饰脂质体包装ASFV,CP204L基因,多功能载药脂质体定制服务 |
88 |
axc |
2024-12-18 |
| 74897 |
DOTA-βA-NH2 |
89 |
h |
2024-12-18 |
| 74898 |
Py-ds-dmBut-OPFP，2101206-44-2，ADC定制 |
73 |
wyh |
2024-12-18 |
| 74899 |
ALD-di-EG-OPFP，ADC定制 |
70 |
wyh |
2024-12-18 |
| 74900 |
cas:2055047-18-0，Azido-PEG3-Val-Cit-PAB-PNP，叠氮-三聚乙二醇-VAL-CIT-PAB-PNP 酯 |
63 |
kx |
2024-12-18 |
| 74901 |
柠檬草精油脂质体,LONL,载药脂质体定制服务 |
97 |
axc |
2024-12-18 |
| 74902 |
cas:159857-79-1，Val-cit-PAB-OH，ADC定制 |
71 |
wyh |
2024-12-18 |
| 74903 |
双载IR780与HCQ的温敏脂质体（IR780/HCQ-Lip） |
115 |
axc |
2024-12-18 |
| 74904 |
endo BCN-PEG3-Val-Cit，(1R,8S,9S)-双环[6.1.0]壬-三聚乙二醇-VAL-CIT |
67 |
kx |
2024-12-18 |
| 74905 |
DOTA-(PEG28)2-A20FMDV2 双末端聚乙二醇化的A20FMDV2偶联DOTA大环配体 |
82 |
h |
2024-12-18 |
| 74906 |
PEG2K-Hyd-PEI聚合物包裹共载SS31肽和胰岛素的脂质体纳米粒,PHP-DPS@INS,NPs |
94 |
axc |
2024-12-18 |
| 74907 |
cas:2226472-28-0 ，DBCO-PEG4-Val-Cit-PAB-PNP，二苯并环辛炔-四聚乙二醇-VAL-CIT-PAB-PNP 酯 |
75 |
kx |
2024-12-18 |
| 74908 |
FA-PEG-DOTA 叶酸-聚乙二醇-DOTA |
64 |
h |
2024-12-18 |
| 74909 |
OA-PEG5烷基链定制 |
105 |
zyl |
2024-12-18 |
| 74910 |
共载SS31肽和胰岛素的脂质体纳米粒,DPS@INS,NPs,脂质体纳米载体定制服务 |
93 |
axc |
2024-12-18 |
| 74911 |
DOTA-PEG27-Cys-VS |
72 |
h |
2024-12-18 |
| 74912 |
cas:1613321-01-9 ，6-Azidohexanoyl-Val-Cit-PAB，6-叠氮己酰-VAL-CIT-PAB |
64 |
kx |
2024-12-18 |
| 74913 |
MPA-PEG4-GB-6的功能与应用 |
104 |
zyl |
2024-12-18 |
| 74914 |
DOTA-PEG-GA DOTA-聚乙二醇-甘草次酸 |
65 |
h |
2024-12-18 |
| 74915 |
负载吡非尼酮的肺靶向纳米脂质体,GALA-PFD-Lip,多功能载药脂质体定制服务 |
127 |
axc |
2024-12-18 |
| 74916 |
PAMAM-PG-g-s-s-DOTA(Gd)+FA 纳米球状MRI造影剂 |
83 |
h |
2024-12-18 |
| 74917 |
DBCO-Val-Cit-PAB-MMAE，二苯并环辛炔-VAL-CIT-PAB-MMAE |
58 |
kx |
2024-12-18 |
| 74918 |
脂质体包裹噬菌体ABSZ6（LIP-ABSZ6），载药脂质体定制服务 |
220 |
axc |
2024-12-18 |
| 74919 |
DOTA-3G3-dimer DOTA-3G3-二聚体 |
68 |
h |
2024-12-18 |
| 74920 |
CAS: 1884578-27-1 Alloc-Val-Ala-PAB-PNP |
75 |
WYQ |
2024-12-18 |
| 74921 |
cas:646502-53-6 ，MC-Val-Cit-PAB-MMAE，VCMMAE 单甲基奥瑞他汀E |
84 |
kx |
2024-12-18 |
| 74922 |
布地奈德脂质体,Budesonide,liposomes,BUD-LNPs,靶向脂质体定制服务 |
91 |
axc |
2024-12-18 |
| 74923 |
DOTA-Lys-PEG4-[D-Phe6,Sta13]-BN(6-14)NH2(HZ219)DOTA缀合的GRPr拮抗剂 |
72 |
h |
2024-12-18 |
| 74924 |
[131I]SIB-PEG4-CHC 聚乙二醇化秋水仙素衍生物-定制 |
115 |
zyl |
2024-12-18 |
| 74925 |
PEG-G5.NH2-FITC-DOTA(Gd)-Monalizumab/IPH4301纳米探针 |
66 |
h |
2024-12-18 |
齐岳微信公众号
官方微信
库存查询